Disease: Pneumocystis jirovecii pneumonia

Clinical Mycology Today: Emerging Challenges and Opportunities

Fungal infections are becoming more common due to new cancer treatments and other medical advances, while some fungal species are developing resistance to standard antifungal medications. The good news is that several new antifungal drugs are in development with better safety profiles and novel mechanisms to fight these infections. However, the field faces challenges including limited specialized mycologists and difficulty designing clinical trials to properly test new treatments.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, especially in patients whose immune systems are weakened. The researchers found that while most hospitals have good access to testing and antifungal medications, some important tests are still missing, and many hospitals send samples to other facilities for testing, which can delay treatment. Since this region has unusually high rates of fungal infections that resist common antifungal drugs, improving access to advanced diagnostic tests is crucial for patient survival.

Read More »

Recognizing the Importance of Public Health Mycology

This editorial highlights how fungal infections are a growing but overlooked global health crisis, killing about 2.5 million people annually. The paper brings together seven research articles studying different fungal diseases, from lung infections to skin conditions, showing how these diseases spread differently in different populations and how resistance to antifungal medications is increasing. The authors emphasize that better testing, treatment access, and worldwide disease tracking are urgently needed, especially in poorer countries where the burden of fungal disease is highest.

Read More »

Photo Quiz: A cutaneous fungal infection with discordant biomarker results—a diagnostic challenge

A woman with advanced HIV disease presented with unusual skin lesions that were initially suspected to be from a virus, but laboratory testing revealed a rare fungal infection called histoplasmosis caused by Histoplasma capsulatum. The case was challenging because some standard fungal tests came back negative even though the patient had the infection, showing why doctors need to rely on culture and examination under the microscope. She was treated with antifungal medications and her diagnosis highlights the importance of considering fungal infections in severely immunocompromised patients even when initial tests seem negative.

Read More »
Scroll to Top